Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Primary antiretroviral drug resistance in newly human immunodeficiency virus-diagnosed individuals testing anonymously and confidentially.

Microbial drug resistance (Larchmont, N.Y.) - 1 Jun 2011

Markovitz Amanda R, Thibault Christina S, Brandauer Peter W, Buskin Susan E

Abstract excerpt

The purpose of this study was to determine if anonymous and confidential testers differ in recency of human immunodeficiency virus (HIV) infection at time of testing and prevalence of antiretroviral drug (ARV) resistance. We examined data from the Centers for Disease Control and Prevention-sponsored Antiretroviral Drug Resistance Testing project, which performed genotypic testing on leftover HIV diagnostic serum...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anti-HIV Agents
Share to CD4 Lymphocyte Count

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Colorado

Share to Confidentiality

Share to Drug Resistance, Viral

Share to HIV Infections

Share to Washington

Source

Identifiers

PMID: 21381964
DOI: 10.1089/mdr.2010.0066

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Primary antiretroviral drug resistance in newly human immunodeficiency virus-diagnosed individuals testing anonymously and confidentially.PMID 21381964Read ↗

Characteristics and genotype profiles of antiretroviral-naïve patients entering a Southern US HIV outpatient clinic 2009-2012.Semantic proximity Read ↗

Changes in the use of HIV antiretroviral resistance testing in a large cohort of U.S. patients, 1999 to 2006.Semantic proximity Read ↗

Transmitted HIV-1 drug resistance among young men of color who have sex with men: a multicenter cohort analysis.Semantic proximity Read ↗

Transmitted Antiretroviral Drug Resistance in Individuals with Newly Diagnosed HIV Infection: South Carolina 2005–2009Semantic proximity Read ↗

Lack of resistance to integrase inhibitors among antiretroviral-naive subjects with primary HIV-1 infection, 2007-2013.Semantic proximity Read ↗

Transmitted antiretroviral drug resistance in New York State, 2006-2008: results from a new surveillance system.Semantic proximity Read ↗

Antiretroviral Drug Use and HIV Drug Resistance Among HIV-Infected Black Men Who Have Sex With Men: HIV Prevention Trials Network 061.Semantic proximity Read ↗

Baseline HIV genotype drug resistance testing: is it time for more or less?Semantic proximity Read ↗

Development and validation of an electronic medical record (EMR)-based computed phenotype of HIV-1 infection.Semantic proximity Read ↗

Late presentation and transmitted drug resistance mutations in new HIV-1 diagnoses in Detroit.Semantic proximity Read ↗

Early adoption of HIV-1 resistance testing in the San Diego County Ryan White CARE Act Program: predictors and outcome.Semantic proximity Read ↗

Detection of acute HIV infections in an urban HIV counseling and testing population in the United States.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.